Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers. 

Share:
More In Science
House Collapses Into River in Alaska
City officials in Juneau issued an emergency declaration earlier this week as a glacial break caused major flooding that led to the collapse of a house in a river.
Load More